Genic Co. Ltd (KQ:123330) — Market Cap & Net Worth
Market Cap & Net Worth: Genic Co. Ltd (123330)
Genic Co. Ltd (KQ:123330) has a market capitalization of $129.92 Million (₩191.70 Billion) as of August 1, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #18145 globally and #754 in its home market, demonstrating a 3.16% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Genic Co. Ltd's stock price ₩24500.00 by its total outstanding shares 7824686 (7.82 Million). See Genic Co. Ltd capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Genic Co. Ltd Market Cap History: 2015 to 2026
Genic Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $150.56 Million to $129.92 Million (-2.66% CAGR).
Index Memberships
Genic Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$202.56 Billion | 0.06% | #273 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$202.56 Billion | 0.06% | #273 of 1384 |
Weight: Genic Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Genic Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Genic Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Genic Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Genic Co. Ltd's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $79.78 Million | $89.67 Billion | $1.23 Billion | 0.00x | 0.07x |
| 2017 | $63.37 Million | $64.69 Billion | -$7.47 Billion | 0.00x | N/A |
| 2018 | $34.84 Million | $69.03 Billion | -$15.32 Billion | 0.00x | N/A |
| 2019 | $26.09 Million | $52.26 Billion | -$11.96 Billion | 0.00x | N/A |
| 2020 | $19.49 Million | $42.13 Billion | -$4.35 Billion | 0.00x | N/A |
| 2021 | $32.77 Million | $38.41 Billion | -$4.33 Billion | 0.00x | N/A |
| 2022 | $23.33 Million | $31.45 Billion | -$3.34 Billion | 0.00x | N/A |
| 2023 | $19.09 Million | $28.07 Billion | -$4.41 Billion | 0.00x | N/A |
| 2024 | $121.70 Million | $49.91 Billion | $7.56 Billion | 0.00x | 0.02x |
| 2025 | $87.60 Million | $78.20 Billion | $18.89 Billion | 0.00x | 0.00x |
Competitor Companies of 123330 by Market Capitalization
Companies near Genic Co. Ltd in the global market cap rankings as of August 1, 2026.
Key companies related to Genic Co. Ltd by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #46 globally with a market cap of $337.63 Billion USD.
- LOREAL ADR 1/5/EO 02 (F:LORA): Ranked #97 globally with a market cap of $204.17 Billion USD ( €174.64 Billion EUR).
- LOréal S.A. (PA:OR): Ranked #109 globally with a market cap of $188.75 Billion USD ( €161.45 Billion EUR).
- Unilever PLC (NASDAQ:UNLYD): Ranked #196 globally with a market cap of $120.76 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #46 | Procter & Gamble Company | NYSE:PG | $337.63 Billion | $144.49 |
| #97 | LOREAL ADR 1/5/EO 02 | F:LORA | $204.17 Billion | €72.00 |
| #109 | LOréal S.A. | PA:OR | $188.75 Billion | €386.95 |
| #196 | Unilever PLC | NASDAQ:UNLYD | $120.76 Billion | $55.38 |
Genic Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Genic Co. Ltd's market cap moved from $150.56 Million to $ 129.92 Million, with a yearly change of -2.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩129.92 Million | +48.31% |
| 2025 | ₩87.60 Million | -28.02% |
| 2024 | ₩121.70 Million | +537.50% |
| 2023 | ₩19.09 Million | -18.18% |
| 2022 | ₩23.33 Million | -28.80% |
| 2021 | ₩32.77 Million | +68.16% |
| 2020 | ₩19.49 Million | -25.30% |
| 2019 | ₩26.09 Million | -25.11% |
| 2018 | ₩34.84 Million | -45.02% |
| 2017 | ₩63.37 Million | -20.57% |
| 2016 | ₩79.78 Million | -47.01% |
| 2015 | ₩150.56 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Genic Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $129.92 Million USD |
| MoneyControl | $129.92 Million USD |
| MarketWatch | $129.92 Million USD |
| marketcap.company | $129.92 Million USD |
| Reuters | $129.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Genic Co. Ltd
Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; a… Read more